- Salmonella Tied to Eggs Sickens 65 in Nine States
- Missouri Patient Hospitalized With Bird Flu Had No Known Contact With Animals
- ‘Night Owls’ More Prone to Type 2 Diabetes
- Obesity Raises Risk of Severe Infection, Especially in People With Diabetes
- Stopping a Bird Flu Epidemic: What Experts Say Must Be Done
- Vaping Could Make Young Adults Physically Weaker
- Moms, Don’t Meddle With Your Kids’ Friends: It’ll Only Make Things Worse
- Flying Could Upset Insulin Pump Function for Type 1 Diabetics
- Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection
- Healthy Tips to Protect Your Eyes’ Retinas as You Age
New Test Helps Diagnose Intellectual Disability in Children
A new test to help diagnose developmental delays and intellectual disability in children based on genetic abnormalities has been approved by the U.S. Food and Drug Administration.
The Affymetrix CytoScan DX Assay scans the entire genetic code from a blood sample and detects chromosomal variations that can lead to developmental and learning problems in children, the agency said Friday in a news release.
Intellectual disability affects as many as 3 percent of children in the United States, the agency said.
Analysis of 960 blood specimens found the new test was better at detecting chromosomal abnormalities that could lead to intellectual disability than other standard tests, the FDA said.
The new test is produced by Affymetrix Inc., based in Santa Clara, Calif.
More information
Medline Plus has more about intellectual disability.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.